GPP
Great Point Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-311,217
| Closed | -$8.03M | – | 29 |
|
|
2021
Q1 | $8.03M | Sell |
311,217
-409,285
| -57% | -$10.6M | 1.66% | 21 |
|
|
2020
Q4 | $38.5M | Sell |
720,502
-1,201,061
| -63% | -$64.2M | 6.26% | 4 |
|
|
2020
Q3 | $79.3M | Buy |
1,921,563
+116,570
| +6% | +$4.81M | 7.13% | 3 |
|
|
2020
Q2 | $87.5M | Sell |
1,804,993
-190,754
| -10% | -$9.25M | 6.99% | 4 |
|
|
2020
Q1 | $84.3M | Buy |
1,995,747
+745,747
| +60% | +$31.5M | 8.81% | 1 |
|
|
2019
Q4 | $53.5M | Sell |
1,250,000
-940,742
| -43% | -$40.2M | 4.66% | 9 |
|
|
2019
Q3 | $78.8M | Buy |
2,190,742
+690,742
| +46% | +$24.9M | 7.24% | 3 |
|
|
2019
Q2 | $40.1M | Sell |
1,500,000
-500,000
| -25% | -$13.4M | 4.45% | 9 |
|
|
2019
Q1 | $53.7M | Sell |
2,000,000
-752,256
| -27% | -$20.2M | 5.32% | 5 |
|
|
2018
Q4 | $44.5M | Buy |
2,752,256
+1,556,158
| +130% | +$25.2M | 5.63% | 5 |
|
|
2018
Q3 | $24.8M | Sell |
1,196,098
-803,902
| -40% | -$16.7M | 3.87% | 13 |
|
|
2018
Q2 | $30.5M | Buy |
+2,000,000
| New | +$30.5M | 4.23% | 9 |
|
|
2017
Q1 | – | Sell |
-270,000
| Closed | -$7.79M | – | 33 |
|
|
2016
Q4 | $7.79M | Buy |
+270,000
| New | +$7.79M | 1.6% | 19 |
|
|
2016
Q2 | – | Sell |
-100,000
| Closed | -$2.8M | – | 38 |
|
|
2016
Q1 | $2.8M | Buy |
+100,000
| New | +$2.8M | 1% | 23 |
|